TSS
AZN icon

Two Sigma Securities’s AstraZeneca AZN Stock Holding History

Two Sigma Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$631K Buy
+3,201
New +$617K 0.07% 382
2025
Q1 		– Sell
-1,584
Closed -$208K – 1471
2024
Q4 		$208K Sell
1,584
-83,524
-98% -$11.7M 0.03% 966
2024
Q3 		$13.3M Buy
85,108
+69,972
+462% +$11.3M 0.22% 101
2024
Q2 		$2.36M Buy
15,136
+3,782
+33% +$569K 0.03% 645
2024
Q1 		$1.54M Buy
11,354
+9,030
+389% +$1.2M 0.01% 895
2023
Q4 		$313K Sell
2,324
-27,091
-92% -$3.52M ﹤0.01% 1963
2023
Q3 		$3.98M Buy
+29,415
New +$4.02M 0.04% 430
2023
Q2 		– Sell
-5,858
Closed -$862K – 2773
2023
Q1 		$813K Sell
5,858
-210
-3% -$28.3K 0.02% 951
2022
Q4 		$823K Buy
+6,068
New +$761K 0.02% 786
2022
Q2 		– Sell
-3,940
Closed -$517K – 2212
2022
Q1 		$523K Buy
+3,940
New +$472K 0.02% 986
2021
Q4 		– Sell
-2,776
Closed -$333K – 1544
2021
Q3 		$333K Sell
2,776
-859
-24% -$100K 0.01% 955
2021
Q2 		$435K Buy
+3,635
New +$399K 0.01% 739
2020
Q2 		– Sell
-2,295
Closed -$205K – 1359
2020
Q1 		$205K Sell
2,295
-2,564
-53% -$241K ﹤0.01% 1053
2019
Q4 		$484K Buy
4,859
+1,023
+27% +$96.3K ﹤0.01% 1465
2019
Q3 		$342K Buy
3,836
+632
+20% +$54.8K ﹤0.01% 1447
2019
Q2 		$264K Buy
+3,204
New +$251K ﹤0.01% 1529
2019
Q1 		– Sell
-3,066
Closed -$242K – 1827
2018
Q4 		$233K Sell
3,066
-27,530
-90% -$2.15M ﹤0.01% 1590
2018
Q3 		$2.42M Buy
30,596
+20,225
+195% +$1.53M 0.02% 621
2018
Q2 		$728K Sell
10,371
-13,552
-57% -$975K ﹤0.01% 1543
2018
Q1 		$1.67M Buy
+23,923
New +$1.66M 0.01% 975

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Two Sigma Securities's AZN Position: Q1 2026 in Review

Two Sigma Securities opened a new position in AstraZeneca (AZN) in Q1 2026: 3,201 shares worth $631K. The stake represents 0.07% of the portfolio and ranks #382 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in AZN as recently as Q4 2024.

Two Sigma Securities first reported a position in AZN in Q1 2018 and has held it in 20 quarters since. The position peaked at $13.3M in Q3 2024. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Two Sigma Securities held 3,201 shares of AstraZeneca worth $631K as of Q1 2026.
  • AstraZeneca was a new Two Sigma Securities position in Q1 2026.
  • AstraZeneca made up 0.07% of Two Sigma Securities's portfolio in Q1 2026, its #382 holding.
  • Two Sigma Securities first reported a position in AstraZeneca in Q1 2018 and has held it in 20 quarters since.
  • Two Sigma Securities's AstraZeneca position peaked at $13.3M in Q3 2024.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.